New hope for tough cancers: experimental drug DPTX3186 enters first human trial
Disease control
Recruiting now
This early-stage study tests an experimental oral drug called DPTX3186 in 40 adults with advanced solid tumors (like colorectal, gastric, lung, or triple-negative breast cancer) that are linked to a specific cell signal called Wnt. These participants have no other approved treatm…
Phase: PHASE1 • Sponsor: Dewpoint Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC